Cargando…

S128. CORRELATION OF DURATION OF UNTREATED PSYCHOSIS WITH TREATMENT RESPONSE ON THE SYMPTOM DIMENSIONS OF SCHIZOPHRENIA

BACKGROUND: Longer duration of untreated psychosis (DUP) predicts worse response to treatment and functional outcomes in first episode of schizophrenia (FES). Longer DUP also seem to particulary affect the severity of negative symptoms, but most studies enrolled previously medicated patients and did...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elias, Beatriz Yukie, Tonsig, Daniela Koga, Bertolucci, Bruno, Noto, Cristiano, Cavalcante, Daniel Azevedo, Cordeiro, Quirino, Bressan, Rodrigo, Gadelha, Ary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888762/ http://dx.doi.org/10.1093/schbul/sby018.915

Ejemplares similares

O8.2. DURATION OF UNTREATED PSYCHOSIS (DUP) IS ASSOCIATED WITH WORSE RESPONSE TO TREATMENT IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOSIS
por: Cavalcante, Daniel, et al.
Publicado: (2018)

T119. NO DIFFERENCE BETWEEN VOLITIVE AND EXPRESSIVE NEGATIVE SYMPTOMS FOR EARLY TREATMENT RESPONSE IN FIRST EPISODE OF PSYCHOSIS ANTIPSYCHOTIC NAïVE PATIENTS
por: Haguiara, Bernardo, et al.
Publicado: (2020)

T97. CANNABIS USE IMPACTS SYMPTOM PRESENTATION IN ANTIPSYCHOTIC NAIVE PATIENTS IN FIRST EPISODE OF PSYCHOSIS (FEP)
por: Coutinho, Luccas, et al.
Publicado: (2018)

T121. BLUNTED AFFECT EARLY PROGRESSION IN DRUG-NAïVE FIRST EPISODE SCHIZOPHRENIA PATIENTS: 10-WEEK FOLLOW UP
por: Kagan, Simão, et al.
Publicado: (2020)

Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia
por: Koga, Gabriela, et al.
Publicado: (2022)

F91. ASSOCIATION BETWEEN SYMPTOM DIMENSIONS AND EXECUTIVE FUNCTION IN SCHIZOPHRENIA
por: Franco, Ana Luiza, et al.
Publicado: (2018)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

F119. MULTILEVEL ANALYSIS IMPROVES THE MODEL FIT OF THE DIMENSIONAL STRUCTURE OF THE PANSS IN PATIENTS WITH SCHIZOPHRENIA
por: Higuchi, Cinthia, et al.
Publicado: (2018)

Effects of Risperidone on Cytokine Profile in Drug-Naïve First-Episode Psychosis
por: Noto, Cristiano, et al.
Publicado: (2015)

Evaluation of the efficacy of transcranial direct current stimulation in the treatment of cognitive symptomatology in the early stages of psychosis: study protocol for a double-blind randomized controlled trial
por: Rabanea-Souza, Thais, et al.
Publicado: (2019)

T117. INVESTIGATION OF FORMAL THOUGHT DISORDER AND RESPONSE TO TREATMENT IN SCHIZOPHRENIA
por: Loures Malinowski, Fernando Rocha, et al.
Publicado: (2018)

Exploration of symptom dimensions and duration of untreated psychosis within a staging model of schizophrenia spectrum disorders
por: Berendsen, Steven, et al.
Publicado: (2020)

O1.4. HOW THE MOST CITED RESEARCH ARTICLES ABOUT SCHIZOPHRENIA IN 2018 DEPICT THE DISEASE?
por: Tonsig, Gabriela, et al.
Publicado: (2020)

Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia
por: Pinaya, Walter H. L., et al.
Publicado: (2016)

Hair cortisol in drug-naïve first-episode individuals with psychosis
por: Andrade, Elvis H., et al.
Publicado: (2016)

A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?
por: Nani, João V, et al.
Publicado: (2020)

T100. NICOTINE USE IMPACTS NEGATIVE SYMPTOMS SEVERITY IN SCHIZOPHRENIA
por: Oliveira, Hianna, et al.
Publicado: (2018)

S129. DOES TREATMENT RESISTANT SCHIZOPHRENIA PRESENT A CHARACTERISTIC SYMPTOMATIC SIGNATURE?
por: Bertolucci, Bruno, et al.
Publicado: (2018)

Short-term Clinical Outcome of Previously Untreated and Treated Schizophrenia and Impact of Duration of Untreated Psychosis
por: Bansal, Priyanka, et al.
Publicado: (2023)

How challenging is to manage agitated patients?
por: Cavalcante, Daniel A., et al.
Publicado: (2019)

Prognostic value of duration of untreated psychosis in long-term outcome of schizophrenia
por: Cechnicki, Andrzej, et al.
Publicado: (2011)

Gene expression over the course of schizophrenia: from clinical high-risk for psychosis to chronic stages
por: Ota, Vanessa Kiyomi, et al.
Publicado: (2019)

Duration Of Untreated Psychosis Among Patients With Schizophrenia – Change Over Time Study
por: Nivedita, .S, et al.
Publicado: (2022)

Correlation between duration of untreated psychosis and long-term prognosis in chronic schizophrenia
por: Yu, Minglan, et al.
Publicado: (2023)

Examining evidence for neighbourhood variation in the duration of untreated psychosis
por: Kirkbride, J.B., et al.
Publicado: (2010)

Clinical Predictors of Duration of Untreated Psychosis: Exploring Psychosocial and Clinical Predictors of Duration of Untreated Psychosis in First-Episode Psychotic Patients in Mzuzu, Malawi
por: Myaba, Japhet, et al.
Publicado: (2021)

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
por: Santoro, Marcos Leite, et al.
Publicado: (2018)

Influence of duration of untreated psychosis on the short-term outcome of drug-free schizophrenia patients
por: Philip, Mariyamma, et al.
Publicado: (2003)

Prospective study of duration of untreated psychosis and outcome of never-treated patients with schizophrenia in India
por: Thirthalli, Jagadisha, et al.
Publicado: (2011)

Impact of duration of untreated psychosis on the treatment outcome among first episode schizophrenia patients.
por: Fatima, Syeda Nissar, et al.
Publicado: (2022)

Pathways to Care: Duration of Untreated Psychosis from Karachi, Pakistan
por: Naqvi, Haider A., et al.
Publicado: (2009)

F256. CAN WE REDUCE THE DURATION OF UNTREATED PSYCHOSIS?
por: Oliver, Dominic, et al.
Publicado: (2018)

What are the physical and mental health implications of duration of untreated psychosis?
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2021)

Effects of duration of untreated psychosis on long-term outcome of people hospitalized with first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2010)

The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data
por: Gouvêa, Eduardo S., et al.
Publicado: (2017)

Duration of Untreated Psychosis in Chinese and Mauritian: Impact of Clinical Characteristics and Patients’ and Families’ Perspectives on Psychosis
por: Devi Thakoor, Jaya Prishni, et al.
Publicado: (2016)

T135. NEIGHBORHOOD-LEVEL PREDICTORS OF AGE AT ONSET AND DURATION OF UNTREATED PSYCHOSIS IN FIRST-EPISODE PSYCHOSIS
por: Ku, Benson, et al.
Publicado: (2018)

The Influence of Mental Health Literacy, Migration, and Education on the Duration of Untreated Psychosis
por: Takizawa, Naomi, et al.
Publicado: (2021)

The duration of untreated psychosis among U.S. Latinxs and social and clinical correlates
por: Santos, Maria M., et al.
Publicado: (2023)

Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia
por: Barnes, Thomas R. E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_i9ujv4vrlutaiv9jkskest194i